Abstract

Cellular functions such as DNA replication and protein translation are influenced by changes in the intracellular redox milieu. Exogenous (i.e., nutrients, deterioration of media components, xenobiotics) and endogenous factors (i.e., metabolism, growth) may alter the redox homeostasis of cells. Thus, monitoring redox changes in real time and in situ is deemed essential for optimizing the production of recombinant proteins. Recently, different redox-sensitive variants of green fluorescent proteins (e.g., rxYFP, roGFP2, and rxmRuby2) have been engineered and proved suitable to detect, in a non-invasive manner, perturbations in the pool of reduced and oxidized glutathione, the major low molecular mass thiol in mammals. In this study, we validate the use of cytosolic rxYFP on two cell lines widely used in biomanufacturing processes, namely, CHO-K1 cells expressing the human granulocyte macrophage colony-stimulating factor (hGM-CSF) and HEK-293. Flow cytometry was selected as the read-out technique for rxYFP signal given its high-throughput and statistical robustness. Growth kinetics and cellular metabolism (glucose consumption, lactate and ammonia production) of the redox reporter cells were comparable to those of the parental cell lines. The hGM-CSF production was not affected by the expression of the biosensor. The redox reporter cell lines showed a sensitive and reversible response to different redox stimuli (reducing and oxidant reagents). Under batch culture conditions, a significant and progressive oxidation of the biosensor occurred when CHO-K1-hGM-CSF cells entered the late-log phase. Medium replenishment restored, albeit partially, the intracellular redox homeostasis. Our study highlights the utility of genetically encoded redox biosensors to guide metabolic engineering or intervention strategies aimed at optimizing cell viability, growth, and productivity.

Highlights

  • Introduction published maps and institutional affilMammalian cell lines have become the dominant system for the production of recombinant proteins for clinical applications, mainly due to their ability to produce diverse, correctly folded, and glycosylated proteins [1]

  • Among the different fluorescent protein-based redox biosensors suitable for monitoring intracellular redox changes, we opted for rxYFP and roGFP2 given that they present high quantum yields and most flow cytometry devices are equipped with the corresponding laser/filter to detect their fluorescence

  • Stable cell lines of Chinese hamster ovary (CHO)-K1-human granulocyte macrophage colony-stimulating factor (hGM-CSF) and human embryo kidney 293 (HEK-293) expressing the rxYFP protein could be obtained after 30 days of antibiotic selection

Read more

Summary

Introduction

Mammalian cell lines have become the dominant system for the production of recombinant proteins for clinical applications, mainly due to their ability to produce diverse, correctly folded, and glycosylated proteins [1]. Compared to other cell systems, protein production by mammalian cells is limited because of the low yields and low processing rate. Over the last 20 years an increase in process yields from 0.5 to 9 g/L was achieved [2]. In order to optimize the production process, several parameters such as cell growth and division, metabolic activity, and physiological stress have been evaluated. Oxidative stress produced under hypoxic and hyperoxic conditions is associated with an increase in the metabolic flux towards the oxidative phosphorylation iations

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call